Pharmacotherapy of borderline personality disorder

被引：0
|
作者：
Hirschfeld, RMA [1 ]
机构：
[1] Univ Texas, Med Branch, Dept Psychiat & Behav Sci, Galveston, TX 77555 USA
来源：
JOURNAL OF CLINICAL PSYCHIATRY | 1997年 / 58卷
关键词：
D O I：
暂无
中图分类号：
B849 [应用心理学];
学科分类号：
040203 ;
摘要：
Borderline personality disorder can be classified into four groups of symptoms: affective, impulsive, ego-interpersonal, and psychotic. Pharmacotherapy of borderline personality disorder should be directed at the severity of the symptoms in each of these groups, rather than by the presence or absence of the overall syndrome. This article reviews the pharmacotherapy of borderline personality disorder, with special emphasis on affective and impulsive symptoms. Overall, the MAOIs, the SSRIs, and the newer antidepressants (such as venlafaxine) provide the widest spectrum of effective treatment for the symptoms of borderline personality disorder.
引用
收藏
页码：48 / 53
页数：6
相关论文
共 50 条
  • [31] Pharmacotherapy for Borderline Personality Disorder: an Update of Published, Unpublished and Ongoing Studies
    Stoffers-Winterling, Jutta
    Storebo, Ole Jakob
    Lieb, Klaus
    CURRENT PSYCHIATRY REPORTS, 2020, 22 (08)
  • [32] Pharmacotherapy for Borderline Personality Disorder: an Update of Published, Unpublished and Ongoing Studies
    Jutta Stoffers-Winterling
    Ole Jakob Storebø
    Klaus Lieb
    Current Psychiatry Reports, 2020, 22
  • [33] Treat borderline personality disorder with psychotherapy and concomitant psychiatric disorders with adjuvant pharmacotherapy
    Esther S. Kim
    Yvette N. Lamb
    Drugs & Therapy Perspectives, 2024, 40 : 17 - 21
  • [34] Current Evidence of Efficacy of Pharmacotherapy for Borderline Personality Disorder (BPD) - A Cochrane Review
    Stoffers, Jutta M.
    Vollm, Birgit A.
    Ruecker, Gerta
    Timmer, Antje
    Lieb, Klaus
    JOURNAL OF PERSONALITY DISORDERS, 2011, 25 : 60 - 61
  • [35] Combined treatment of borderline personality disorder with interpersonal psychotherapy and pharmacotherapy: Predictors of response
    Bellino, Silvio
    Bozzatello, Paola
    Bogetto, Filippo
    PSYCHIATRY RESEARCH, 2015, 226 (01) : 284 - 288
  • [36] Overview of the Pharmacotherapy of Borderline Personality Disorder: Should We Rethink the APA Algorithm?
    Silk, Kenneth R.
    JOURNAL OF PERSONALITY DISORDERS, 2011, 25 : 6 - 6
  • [37] Treat borderline personality disorder with psychotherapy and concomitant psychiatric disorders with adjuvant pharmacotherapy
    Kim, Esther S.
    Lamb, Yvette N.
    DRUGS & THERAPY PERSPECTIVES, 2024, 40 (01) : 17 - 21
  • [38] The Efficacy of Pharmacotherapy for Borderline Personality Disorder: A Review of the Available Randomized Controlled Trials
    Francois, Dimitry
    Roth, Steven D.
    Klingman, Daisy
    PSYCHIATRIC ANNALS, 2015, 45 (08) : 431 - 437
  • [39] Combined treatment of major depression in patients with borderline personality disorder: A comparison with pharmacotherapy
    Bellino, S
    Zizza, M
    Rinaldi, C
    Bogetto, F
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2006, 51 (07): : 453 - 460
  • [40] Aripiprazole pharmacotherapy of borderline personality disorder - A series of three consecutive case reports
    Mobascher, A.
    Mobascher, J.
    Schlemper, V.
    Winterer, G.
    Malevani, J.
    PHARMACOPSYCHIATRY, 2006, 39 (03) : 111 - 112
12345